AUS
NZ
UK
CA
USA
IND
Healthcare
SUDA Reports Significant Preliminary Results from Anagrelide Pharmacokinetic Study
May 28, 2020 05:07 PM AEST| By Team Kalkine MediaSummary SUDA made further progress towards Anagrelide program, attaining significant preliminary results from a pharmacokinetic study. Results support SUDA’s hypothesis that Anagrelide’s mouth spray formulation can lessen the risk o.....
Impressive! Prescient Obtains Key Licenses for Next Generation Immunotherapy Platform
May 28, 2020 11:45 AM AEST| By Team Kalkine MediaSummary Prescient obtains two key licenses from world immunotherapy leader, University of Pennsylvania and Oxford University to create a revolutionary cancer therapy platform called “OmniCAR”. OmniCAR platform would allow extraordin.....
5 Growth Stocks that are Investors’ Favourite during COVID-19
May 28, 2020 12:10 AM AEST| By Kunal SawhneySummary A few growth stocks like Amazon, Google, Microsoft, Tesla, etc have consistently been providing the investors with high yields. Pushpay Holdings delivered an exponential return of 24 per cent on YTD basis (as on 26 May 2020). Nanosoni.....
Radical Shifts to Occur in Popular Index Compositions Amidst COVID-19 Crisis
May 27, 2020 12:00 AM AEST| By Team Kalkine MediaCoronavirus pandemic has profoundly impacted the world, causing a threat to public health, disrupting social and economic dynamics while affecting long-term livelihoods and well-being of millions. Market analysts and experts are fearing a r.....
Nyrada Announces Milestone Achieved in Brain Injury Program; Strong Leadership Fostering Success Story
May 26, 2020 05:06 PM AEST| By Team Kalkine MediaAustralian preclinical stage and publicly listed drug development company, Nyrada Inc. (ASX: NYR) is marking good progress towards developing novel small molecule drugs targeted at treating neurological, cardiovascular and inflammatory diseases, with...
How Does Gilead’s Antiviral Drug Remdesivir Help to Combat COVID-19?
May 26, 2020 12:35 AM AEST| By Team Kalkine MediaSummary As of now, there are more than 5.2 million confirmed cases of COVID-19, and over 337k deaths have been reported. There is no approved vaccine for COVID-19 although dozens of candidates are under clinical development. Amid this crisis,.....
Airline Industry Stemming for Revival after COVID-19 Disruptions
May 25, 2020 03:23 PM AEST| By Team Kalkine MediaTravel and tourism contributed more than 10% to the Australian economy in 2019, as per WTTC; however, lockdowns and travel restrictions arising from the virus spread severely impacted the industry in first half of 2020. Revival of the travel and .....
Noxopharm’s potential COVID-19 treatment - Lodges pre-IND Submission with FDA for Veyonda® Clinical Trial
May 25, 2020 01:02 PM AEST| By Team Kalkine MediaMarking a step forward, clinical-stage drug development company Noxopharm (ASX:NOX) has lodged a pre-IND (Investigational New Drug) submission with the U.S. Food and Drug Administration (FDA) for a Veyonda® clinical trial in COVID-19 (SARS-C...
Antisense and Invex - Why these two ASX-healthcare Players might be having a good weekend?
May 24, 2020 12:50 AM AEST| By Team Kalkine MediaAmid the unprecedented market instability due to the COVID-19 pandemic, investors are keenly focusing on investing in lucrative shares having the highest value in the market. The coronavirus outbreak has changed the dimensions for the businesses acro...
Biotech player Selvax beating the odds; eyes an IPO in H2’ 20
May 24, 2020 12:10 AM AEST| By Kunal SawhneyThe oncology therapeutic area is still looking for a breakthrough treatment that will establish itself as a go-to-treatment for treating malignancies. Making its way through, a novel cancer immunotherapy treatment has surfaced that provides relativel...
Air pollution likely to reach pre-COVID-19 levels: China sees rise in pollutants post lockdown
May 24, 2020 12:00 AM AEST| By Team Kalkine MediaThe world has seen quality of air deteriorating and amount of pollution levels significantly rising over the last two decades due to burning of fossil fuels in industries and households along with rising number of vehicles on roads. The menace of air...
Can Dimerix follow in the footsteps of Opthea, Paradigm and Antisense?
May 23, 2020 03:25 PM AEST| By Team Kalkine MediaAs the gravity of the coronavirus outbreak continues to intensify, the healthcare sector has been surrounded by the news about the race amongst countries and pharma companies to develop a vaccine for the infectious disease. Several established compan...
Could Herd Immunity Help in Preventing COVID-19?
May 22, 2020 09:21 PM AEST| By Hina ChowdharyCOVID-19, a Public Health Emergency of International Concern, has affected more than 4.9 million lives, destroyed all the health systems and confined billions of individuals in their homes. The world is battling against a pandemic that has had a deva...
Unprecedented Measures in Unprecedented Times: Cafes Innovate amid COVID-19 Scene
May 22, 2020 08:23 PM AEST| By Kunal SawhneyWe are experiencing such times that no one could have imagined in their wildest of dreams. There are new norms to follow, as we are maintaining distance from our fellow humans, due to the fear of this invisible deadly virus as anyone can be the carri...
Retailers Face Ongoing Disruptions from COVID-19 and Increasing Wage Bills
May 22, 2020 07:19 PM AEST| By Team Kalkine MediaSluggish prelim retail numbers as expected… After a strong March for overall retail sales led by panic buying in supermarkets, the latest preliminary data on retail sales by the Australian Bureau of Statistics (ABS) suggested that retail turn...
COVID-19 Market Darlings in the US: DDOG, NOW, TDOC
May 22, 2020 12:59 PM AEST| By Team Kalkine MediaYes, coronavirus has indeed caused havoc for most of the stocks in the market. But some are still shining bright, as their business model appears to be exhibiting resilience amid the pandemic. One has to carefully look at how the business is generati...
No Baby Steps for Baby Bunting, Sales up Double Digits Despite COVID-19
May 21, 2020 01:33 PM AEST| By Team Kalkine MediaBaby Bunting Group Limited (ASX:BBN) is a baby goods retailer and one of the companies enjoying robust trade performance during the corona crisis. In its latest business update, the company reported continuous sales growth. The latest update by Baby...
Japanese Patent Office Accepted SUDA’s Anagrelide Cancer Patent Application; Stock Surged Over 10%
May 21, 2020 12:29 PM AEST| By Team Kalkine MediaThe Japanese Patent Office has accepted Anagrelide cancer patent application, and the patent would now proceed to grant, notified SUDA Pharmaceuticals Ltd (ASX:SUD) in its latest update. The patent “Use of Anagrelide for Treating Cancer”...
Lens on 3 ASX stocks amid COVID-19 pandemic: RAC, GMA, WOR
May 20, 2020 09:59 PM AEST| By Team Kalkine MediaAustralia is one of the few countries that has successfully dealt with the coronavirus pandemic. By adopting various preventive measures and imposing necessary restrictions, the country was able to flatten the virus curve. However, the pandemic has b...
Stocks Paying Dividend During COVID-19 Times; AMC, BKW
May 20, 2020 09:50 PM AEST| By Hina ChowdharyThe outbreak of coronavirus possesses a potential threat to the future of businesses around the globe. Businesses across are conserving cash amidst the uncertainty and boards across businesses are going to the extent of deferring or withdrawal of div...
Advertise your brand on Kalkine Media